Literature DB >> 30633622

Challenges and opportunities of school-based HPV vaccination in Canada.

Eve Dubé1,2,3, Dominique Gagnon1, Paule Clément1, Julie A Bettinger4, Jeannette L Comeau5, Shelley Deeks6,7, Maryse Guay1,8, Shannon MacDonald9, Noni E MacDonald5, Hana Mijovic4, Jillian Paragg8, Clara Rubincam4, Chantal Sauvageau1,2,3, Audrey Steenbeck5, Sarah Wilson6,7.   

Abstract

Primary prevention of human papillomavirus (HPV) through vaccination is a high priority in Canada's cancer prevention efforts. All Canadian provinces and territories have introduced publicly funded, school-based vaccination programs against HPV, but vaccine uptake remains suboptimal in some jurisdictions. We conducted a descriptive qualitative study to better understand the determinants of low HPV vaccine uptake and identify strategies to enhance vaccine acceptance using the socio-ecological model. In Quebec, interviews and focus groups were held in 2015-2016 with 70 key informants including immunization managers, school nurses, school principals, teachers and parents of Grade 4 students (9 years of age). Our findings showed that HPV vaccine uptake was dependent on many interrelated factors at the individual and interpersonal level (e.g. knowledge and attitudes of the different players involved in the vaccination system), at the community level (e.g. social group values and norms, media coverage around the HPV vaccine), at the organizational level (e.g. allocated resources, information provision, consent process, immunization setting and environment) and at the policy level (e.g. changes in provincial HPV vaccine program). We are using the data collection and interpretation tools and approaches developed by our team and used in Quebec to expand our study to four other provinces (British Columbia, Alberta, Ontario and Nova Scotia). We are conducting environmental scans, semi-structured interviews and a survey to better understand the determinants of low HPV vaccine uptake and identify strategies to enhance vaccine acceptance. Having an in-depth understanding of the determinants of HPV vaccination in school settings is critical in order to identify root causes of the suboptimal vaccine uptake and to develop tailored interventions to address these on both supply- and demand-side issues.

Entities:  

Keywords:  HPV vaccine; determinants; immunization managers; interviews; school-based immunization programs; socio-ecological model

Mesh:

Year:  2019        PMID: 30633622      PMCID: PMC6746476          DOI: 10.1080/21645515.2018.1564440

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  10 in total

1.  "It takes time to build trust": a survey Ontario's school-based HPV immunization program ten years post-implementation.

Authors:  Eve Dubé; Sarah Wilson; Dominique Gagnon; Shelley L Deeks; Vinita Dubey
Journal:  Hum Vaccin Immunother       Date:  2020-07-09       Impact factor: 3.452

Review 2.  Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases.

Authors:  Neha Puri; Eric A Coomes; Hourmazd Haghbayan; Keith Gunaratne
Journal:  Hum Vaccin Immunother       Date:  2020-07-21       Impact factor: 3.452

3.  Human papillomavirus (HPV) vaccination across a cascade of knowledge, willingness, and uptake among gay, bisexual, and other men who have sex with men in Canada's three largest cities.

Authors:  R Grewal; S L Deeks; T A Hart; J Cox; A De Pokomandy; T Grennan; G Lambert; D Moore; F Coutlée; M Gaspar; C George; D Grace; J Jollimore; N J Lachowsky; R Nisenbaum; G Ogilvie; C Sauvageau; D H S Tan; A Yeung; A N Burchell
Journal:  Hum Vaccin Immunother       Date:  2021-12-02       Impact factor: 3.452

Review 4.  A Behavioral analysis of nurses' and pharmacists' role in addressing vaccine hesitancy: scoping review.

Authors:  Christine Cassidy; Jodi Langley; Audrey Steenbeek; Beth Taylor; Natalie Kennie-Kaulbach; Hilary Grantmyre; Lillian Stratton; Jennifer Isenor
Journal:  Hum Vaccin Immunother       Date:  2021-08-18       Impact factor: 4.526

Review 5.  There's Much Yet to be Done: Diverse Perspectives on HPV Vaccination.

Authors:  Gregory D Zimet; Nosayaba Osazuwa-Peters
Journal:  Hum Vaccin Immunother       Date:  2019       Impact factor: 3.452

6.  Practice and Associated Factors of Human Papillomavirus Vaccination Among Primary School Students in Minjar-Shenkora District, North Shoa Zone, Amhara Regional State, Ethiopia, 2020.

Authors:  Hareg Nigussie Kassa; Awraris Hailu Bilchut; Abinet Dagnaw Mekuria; Ermias Mekuria Lewetie
Journal:  Cancer Manag Res       Date:  2021-09-07       Impact factor: 3.989

7.  The estimated age-group specific influenza vaccine coverage rates in Hong Kong and the impact of the school outreach vaccination program.

Authors:  Wilfred Hing-Sang Wong; Sinéad Peare; Hiu Ying Lam; Chun Bong Chow; Yu Lung Lau
Journal:  Hum Vaccin Immunother       Date:  2021-10-29       Impact factor: 3.452

8.  Factors associated with human papillomavirus and meningococcal vaccination among adolescents living in rural and urban areas.

Authors:  Thomas G Boyce; Ben Christianson; Kayla E Hanson; Denise Dunn; Elizabeth Polter; Jeffrey J VanWormer; Charnetta L Williams; Edward A Belongia; Huong Q McLean
Journal:  Vaccine X       Date:  2022-06-11

9.  Implementation of the human papillomavirus school-entry requirement in Puerto Rico: barriers and facilitators using the consolidated framework for implementation research.

Authors:  Vivian Colón-López; Roxana Soto-Abreu; Diana T Medina-Laabes; Olga L Díaz-Miranda; Ana P Ortiz; Erick L Suárez; Pamela C Hull
Journal:  Hum Vaccin Immunother       Date:  2021-08-09       Impact factor: 4.526

10.  Non-inferior antibody levels for HPV16/18 after extended two-dose schedules compared with a six-month interval: findings of a systematic review and meta-analysis.

Authors:  Aneisha Collins-Fairclough; Robine Donken; Bohdan Nosyk; Simon Dobson; Gina Ogilivie; Manish Sadarangani
Journal:  Hum Vaccin Immunother       Date:  2021-06-30       Impact factor: 4.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.